Table: Mochida Pharm - 9-MTH group results

Mochida Pharmaceutical Co

30/03/2026 07:30

Mar 30 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             87.49               80.73           115.50    
                 (+8.4 pct)          (+3.2 pct)       (+9.8 pct)  
  Operating          7.53                7.24             9.50    
                 (+3.9 pct)          (+25.1 pct)      (+16.9 pct) 
  Recurring          8.35                7.64            11.00    
                 (+9.2 pct)          (+26.1 pct)      (+36.3 pct) 
  Net                6.34                5.61             8.40    
                 (+13.2 pct)         (+26.1 pct)      (+47.8 pct) 
  EPS            178.91 yen          158.11 yen       236.95 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div         40.00 yen           40.00 yen                   
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T